Ernest B. M.
- Country
- Spain
- Department
- Neurology
Research Overview
- Evaluation of Lu AF28996 in the Treatment of Parkinson's Disease in Affected Patients
- A Phase 1, First-in-Human Study to Evaluate the Safety and Pharmacokinetics of RO7812653 in Patients with Early Symptomatic Alzheimer’s Disease
- A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecal ALN-5288 in Adults with Alzheimer’s Disease
Data & Insights
Has run more than one trial at 145 of 257 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in the study of progressive neurological conditions, with particular emphasis on therapeutic interventions for degenerative brain disorders.
- Early-stage disease detection
- Disease-modifying treatments
- Novel therapeutic approaches
Research encompasses innovative treatment methodologies for managing neurodegenerative progression.
Parkinson's Disease Research
Focused on advancing treatments for Parkinson's disease, including studies of new therapeutic compounds and disease management approaches.
- Motor symptom management
- LRRK2-associated Parkinson's
- Early-stage interventions
Investigates both conventional and innovative treatment delivery systems for symptom control.
Alzheimer's Disease Studies
Conducts research into early Alzheimer's disease treatments, focusing on cognitive function preservation and disease progression modification.
- Cognitive decline intervention
- Tau protein targeting
- Preclinical disease stages
Explores multiple therapeutic pathways including immunotherapy and novel pharmaceutical compounds.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.